Literature DB >> 6191977

Comparison of the promoting effects of various agents in induction of preneoplastic lesions in rat liver.

N Ito, H Tsuda, R Hasegawa, K Imaida.   

Abstract

The promoting activities of 29 compounds on induction of hyperplastic (neoplastic) liver nodules (HN) and the dose-dependent effects of tumor promoting agents were compared by using a short-term test system developed in this laboratory. In tests on promoting activity, F344 rats were given a single dose (200 mg/kg) of N-nitrosodiethylamine (DEN), and from two weeks later, were treated with various test compounds for 6 or 10 weeks. They were subjected to partial hepatectomy 3 or 4 weeks after DEN treatment. The results showed that strong hepatocarcinogens, such as aflatoxin B1, DEN, N-nitrosodimethylamine (DMN), 2-acetylaminofluorene (2-AAF), 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB) and ethionine, induced many hyperplastic liver nodules, whereas dieldrin, 1,1,1-trichloro-2,2-bis(4-chlorophenyl)ethane (DDT), polychlorinated biphenyls (PCB) and alpha-hexachlorocyclohexane (alpha-HCH) induced few lesions. Nonhepatocarcinogens, such as N-nitrosoethylurea (ENU) and 3-methylcholanthrene (3-MC), only slightly induced hyperplastic nodules. Of the miscellaneous compounds tested, phenobarbital, deoxycholic acid and ethynyl estradiol also induced gamma-glutamyl transpeptidase (gamma-GT) positive foci. In tests on the dose-dependent effects of promoting agents, DMN was given at different concentrations for 6 weeks from 2 weeks after DEN treatment. Results were quantitated by histochemical measurement of the number or area of gamma-GT positive lesions induced. A long-term experiment on the effect of feeding DMN for 96 weeks was also done. Clear dose-dependent effects of DMN were seen in induction of gamma-GT positive foci in the short-term experiment and neoplastic lesions in the long-term one.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6191977      PMCID: PMC1569236          DOI: 10.1289/ehp.8350131

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  17 in total

1.  Modification of diethylnitrosamine liver carcinogenesis with phenobarbital but not with immunosuppression.

Authors:  J H Weisburger; R M Madison; J M Ward; C Viguera; E K Weisburger
Journal:  J Natl Cancer Inst       Date:  1975-05       Impact factor: 13.506

2.  Promoting effect of bile acids in colon carcinogenesis in germ-free and conventional F344 rats.

Authors:  B S Reddy; K Watanabe; J H Weisburger; E L Wynder
Journal:  Cancer Res       Date:  1977-09       Impact factor: 12.701

3.  Reduction and enhancement by phenobarbital of hepatocarcinogenesis induced in the rat by 2-acetylaminofluorene.

Authors:  C Peraino; R J Fry; E Staffeldt
Journal:  Cancer Res       Date:  1971-10       Impact factor: 12.701

4.  Promotion of mammary carcinogenesis and leukemogenic action by phorbol in virgin female Wistar rats.

Authors:  V Armuth; I Berenblum
Journal:  Cancer Res       Date:  1974-10       Impact factor: 12.701

5.  Induction of resistant hepatocytes as a new principle for a possible short-term in vivo test for carcinogens.

Authors:  H Tsuda; G Lee; E Farber
Journal:  Cancer Res       Date:  1980-04       Impact factor: 12.701

6.  Effects of varying the dietary concentration of phenobarbital on its enhancement of 2-acetylaminofluorene-induced hepatic tumorigenesis.

Authors:  C Peraino; E F Staffeldt; D A Haugen; L S Lombard; F J Stevens; R J Fry
Journal:  Cancer Res       Date:  1980-09       Impact factor: 12.701

7.  Evaluation of a new model to detect bladder carcinogens or co-carcinogens; results obtained with saccharin, cyclamate and cyclophosphamide.

Authors:  R M Hicks; J Wakefield; J Chowaniec
Journal:  Chem Biol Interact       Date:  1975-09       Impact factor: 5.192

8.  Promoting effect of saccharin and DL-tryptophan in urinary bladder carcinogenesis.

Authors:  S M Cohen; M Arai; J B Jacobs; G H Friedell
Journal:  Cancer Res       Date:  1979-04       Impact factor: 12.701

9.  Sequential quantitative studies on hyperplastic nodules in the liver of rats treated with carcinogenic chemicals.

Authors:  M Tatematsu; G Murasaki; K Nakanishi; Y Miyata; Y Shinohara; N Ito
Journal:  Gan       Date:  1979-02

10.  Long-term experiment of maximal non-carcinogenic dose of dimethylnitrosamine for carcinogenesis in rats.

Authors:  M Arai; Y Aoki; K Nakanishi; Y Miyata; T Mori; N Ito
Journal:  Gan       Date:  1979-08
View more
  9 in total

1.  Changes in cytosolic CA2+ are not involved in DDT-induced loss of gap junctional communication in WB-F344 cells.

Authors:  R Fransson; P Nicotera; L Wärngård; U G Ahlborg
Journal:  Cell Biol Toxicol       Date:  1990-04       Impact factor: 6.691

2.  Inhibition of metabolic cooperation in Chinese hamster lung fibroblast cells (V79) in culture by various DDT-analogs.

Authors:  L Wärngård; S Flodström; S Ljungquist; U G Ahlborg
Journal:  Arch Environ Contam Toxicol       Date:  1985-09       Impact factor: 2.804

Review 3.  Enzymes of glutathione metabolism as biochemical markers during hepatocarcinogenesis.

Authors:  S Hendrich; H C Pitot
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

4.  Effects of tetradecanoyl phorbol acetate, pyrethroids and DDT in the V79.

Authors:  L Wärngård; S Flodström
Journal:  Cell Biol Toxicol       Date:  1989-01       Impact factor: 6.691

5.  Advantages and limitations of stereological estimation of placental glutathione S-transferase-positive rat liver cell foci by computerized three-dimensional reconstruction.

Authors:  K Imaida; M Tatematsu; T Kato; H Tsuda; N Ito
Journal:  Jpn J Cancer Res       Date:  1989-04

6.  Species-specific regulation of PXR/CAR/ER-target genes in the mouse and rat liver elicited by o, p'-DDT.

Authors:  Naoki Kiyosawa; Joshua C Kwekel; Lyle D Burgoon; Edward Dere; Kurt J Williams; Colleen Tashiro; Brock Chittim; Timothy R Zacharewski
Journal:  BMC Genomics       Date:  2008-10-16       Impact factor: 3.969

7.  Three-dimensional analysis of glutathione S-transferase placental form-positive lesion development in early stages of rat hepatocarcinogenesis.

Authors:  T Kato; K Imaida; K Ogawa; R Hesegawa; T Shirai; M Tatematsu
Journal:  Jpn J Cancer Res       Date:  1993-12

8.  Organ-specific modification of tumor development by low-dose combinations of agents in a rat wide-spectrum carcinogenesis model.

Authors:  S Fukushima; M A Shibata; M Hirose; T Kato; M Tatematsu; N Ito
Journal:  Jpn J Cancer Res       Date:  1991-07

9.  Wide-spectrum initiation models: possible applications to medium-term multiple organ bioassays for carcinogenesis modifiers.

Authors:  N Ito; K Imaida; H Tsuda; M Shibata; T Aoki; J L de Camargo; S Fukushima
Journal:  Jpn J Cancer Res       Date:  1988-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.